{"transactions":[{"id":2056900,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":120798,"kind":"person","name":"MARKS LILLY","position":1,"cik":"0001645735","reported_name":"MARKS LILLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-11T21:50:58.000Z","date":"2022-10-31","kind":"grant","acquired":true,"shares":293,"price":13.65,"value":3999.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares purchased pursuant to the Orthofix Medical Inc. Second Amended and Restated Stock Purchase Plan, as Amended (the \"Stock Purchase Plan\") for the plan period ended October 31, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Stock Purchase Plan, shares are purchased at 85% of the fair market value of the Orthofix stock on the first day of the plan period or, if lower, on the last day of the plan period. Accordingly, shares were purchased at $13.65 per share, or at 85% of the quoted market price of $16.06 on October 31, 2022."}],"balance_after":37813,"source":{"system":"sec-edgar","filing":"0001209191-23-003004","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919123003004/doc5.xml","form_type":"5"}},{"id":2239552,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":120798,"kind":"person","name":"MARKS LILLY","position":1,"cik":"0001645735","reported_name":"MARKS LILLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-08T20:30:28.000Z","date":"2022-06-06","kind":"grant","acquired":true,"shares":6383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended.  The award vest in full on the first anniversary of the grant date, June 6, 2022."}],"balance_after":37520,"source":{"system":"sec-edgar","filing":"0001209191-22-035037","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919122035037/doc4.xml","form_type":"4"}},{"id":2657845,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":120798,"kind":"person","name":"MARKS LILLY","position":1,"cik":"0001645735","reported_name":"MARKS LILLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-23T20:31:15.000Z","date":"2021-06-21","kind":"grant","acquired":true,"shares":4313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"). The award vests in full on the first anniversary of the grant date, June 21, 2021."}],"balance_after":30573,"source":{"system":"sec-edgar","filing":"0001209191-21-042747","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919121042747/doc4.xml","form_type":"4"}},{"id":3115346,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":120798,"kind":"person","name":"MARKS LILLY","position":1,"cik":"0001645735","reported_name":"MARKS LILLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-10T22:02:45.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":4588,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"). The award vests in full on the first anniversary of the grant date, June 8, 2020."}],"balance_after":25794,"source":{"system":"sec-edgar","filing":"0001209191-20-035659","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919120035659/doc4.xml","form_type":"4"}},{"id":3491890,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":120798,"kind":"person","name":"MARKS LILLY","position":1,"cik":"0001645735","reported_name":"MARKS LILLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-13T21:58:04.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":3431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"). The award vests in full on the first anniversary of the grant date, June 11, 2019."}],"balance_after":20696,"source":{"system":"sec-edgar","filing":"0001209191-19-036910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919119036910/doc4.xml","form_type":"4"}},{"id":3866730,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":120798,"kind":"person","name":"MARKS LILLY","position":1,"cik":"0001645735","reported_name":"MARKS LILLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-17T23:01:04.000Z","date":"2018-07-17","kind":"grant","acquired":true,"shares":2900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred Stock Unit award granted on July 2, 2018, subject to shareholder approval, which was obtained on July 17, 2018, and is subject to\ndeferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities\nExchange Act of 1934, as amended (the \"Exchange Act\"). These awards vest in full on July 2, 2019."}],"balance_after":16929,"source":{"system":"sec-edgar","filing":"0001209191-18-042916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919118042916/doc4.xml","form_type":"4"}},{"id":4260267,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":120798,"kind":"person","name":"MARKS LILLY","position":1,"cik":"0001645735","reported_name":"MARKS LILLY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-10T21:59:23.000Z","date":"2017-07-03","kind":"grant","acquired":true,"shares":3579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"). These awards vest in full on July 3, 2018. Vested shares of common stock will be delivered to the reporting person within 45 days after termination of service as a director."}],"balance_after":14029,"source":{"system":"sec-edgar","filing":"0001209191-17-044654","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919117044654/doc4.xml","form_type":"4"}}]}